Sandbox Reserved 1769

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 25: Line 25:
NTCP contains two characteristic domains: the core and panel domains. Movement of these two domains allows recognition and transport of bile salts into hepatocytes.
NTCP contains two characteristic domains: the core and panel domains. Movement of these two domains allows recognition and transport of bile salts into hepatocytes.
*<b><font color="orange">Panel Domain</font></b>: 1-44, 155-208
*<b><font color="orange">Panel Domain</font></b>: 1-44, 155-208
-
** Formed by transmembrane helices TM1, TM5, and TM6
+
** Formed by transmembrane helices TM1, TM5, and TM6.
*<b><font color="#0040e0">Core domain</font></b>: 45-154, 209-309
*<b><font color="#0040e0">Core domain</font></b>: 45-154, 209-309
**Formed by the packing of a helix bundle of TM2, TM3, and TM4 with another helix bundle of TM7, TM8, and TM9. These two helix bundles are related by pseudo two-fold symmetry.
**Formed by the packing of a helix bundle of TM2, TM3, and TM4 with another helix bundle of TM7, TM8, and TM9. These two helix bundles are related by pseudo two-fold symmetry.
Line 33: Line 33:
=== Sodium Binding Sites ===
=== Sodium Binding Sites ===
-
To transport a single bile salt from the blood to the cytoplasm of the liver cell, two sodium ions are required to be bound to to NTCP in the open-pore state in association with specific residues of the molecule. This is because the transport of bile salts into the cell is so thermodynamically unfavorable , the reaction has to be coupled to the favorable transport of 2 sodium into into the cell. When the bile salts are released into the cell, the protein is then reverted to the inward facing conformation, in which the pore through which the bile salt had just passed is now closed. This is an example of secondary active transport. The residues interacting with the sodium ion in sodium binding site #1 includes S105, N106, E257, and T123. The residues interacting with the sodium ion in sodium binding site #2 includes Q261 and Q68. Mutations to these significant residues will inhibit the binding of sodium ions, and therefore, inhibit the overall function of NTCP.
+
To transport a single bile salt from the blood to the cytoplasm of the liver cell, two sodium ions are required to be bound to to NTCP in the open-pore state. This is because the transport of bile salts into the cell is so thermodynamically unfavorable that the reaction has to be coupled to the favorable transport of two sodium into into the cell. It is thus an example of secondary active transport (INSERT BLUE LINK). When the bile salts are released into the cell, the protein is then found in the inward facing conformation, in which the pore through which the bile salt had just passed is now closed to the extracellular side. The residues interacting with the sodium ion in sodium binding site #1 include S105, N106, E257, and T123. The residues interacting with the sodium ion in sodium binding site #2 includes Q261 and Q68. Mutations to these significant residues inhibit the binding of sodium ions, and consequently, inhibit the transport of bile salts by NTCP.
<scene name='95/952698/Sodium_binding_sites/1'>TextToBeDisplayed</scene>
<scene name='95/952698/Sodium_binding_sites/1'>TextToBeDisplayed</scene>
=== Significant Residues ===
=== Significant Residues ===
-
The vast majority of residues involved in bile salt uptake are also involved in HBV/HDV infection. <scene name='95/952696/Residues_84-87_1/1'>Residues 84-87</scene> (extracellular view) of Human NTCP have been shown to be vital for preS1 domain recognition along with bile salt uptake. These residues were replaced in mouse NTCP by human NTCP and conferred to successful binding of the virus. These residues are found in the extracellular loop connecting TM2 and TM3. <scene name='95/952696/Residues_157-165/1'>Residues 157-165</scene> (extracellular view) have also been shown to be vital for preS1 recognition and bile salt uptake. These residues were mutated in monkey NTCP to the human residues and preS1 binding was then successful. These residues are found on the N-terminal end of TM5. The absence of residues in either of these <scene name='95/952696/Residues_84-87_and_157-165/1'>two extracellular patches</scene> hinders preS1 binding and therefore HBV/HDV infection. Interestingly, residues 84-87 do not affect bile acid uptake, so it is a potential site for blocking HBV/HDV infection while maintaining NTCP's ability to perform its normal function. Another important residue was discovered to be a [https://en.wikipedia.org/wiki/Single-nucleotide_polymorphism single-nucleotide polymorphism] in a small population in East Asia. <scene name='95/952696/Residue_267/1'>Residue 267</scene>, which is normally serine, being mutated to phenylalanine prevents preS1 binding and does not support bile acid transport. This residue is also found extracellularly, on TM8 of NTCP. There are 3 additional leucine residues that when mutated, block both preS1 binding and HBV/HDV infection. Replacing L27, L31, and L35 (INSERT GREEN LINK) with tryptophan residues presumably blocks the preS1 binding site preventing proper infection.
+
The majority of residues involved in bile salt uptake are also involved in HBV/HDV infection. <scene name='95/952696/Residues_84-87_1/1'>Residues 84-87</scene> (extracellular view) of Human NTCP have been shown to be vital for HBV/HDV virus recognition along with bile salt uptake. These residues were replaced in mice NTCP by human NTCP and conferred to successful binding of the virus. These residues are found in the extracellular loop connecting TM2 and TM3. <scene name='95/952696/Residues_157-165/1'>Residues 157-165</scene> (extracellular view) have also been shown to be vital for HBV/HDV viral recognition and bile salt uptake. These residues were mutated in monkey NTCP to the human residues and preS1 binding was then successful. These residues are found on the N-terminal end of TM5. The absence of residues in either of these <scene name='95/952696/Residues_84-87_and_157-165/1'>two extracellular patches</scene> hinders preS1 binding and therefore HBV/HDV infection. Interestingly, residues 84-87 do not affect bile acid uptake, so it is a potential site for blocking HBV/HDV infection while maintaining NTCP's ability to perform its normal function. Another important residue was discovered to be a [https://en.wikipedia.org/wiki/Single-nucleotide_polymorphism single-nucleotide polymorphism] in a small population in East Asia. <scene name='95/952696/Residue_267/1'>Residue 267</scene>, which is normally serine, being mutated to phenylalanine prevents preS1 binding and does not support bile acid transport. This residue is also found extracellularly, on TM8 of NTCP. There are 3 additional leucine residues that when mutated, block both preS1 binding and HBV/HDV infection. Replacing L27, L31, and L35 (INSERT GREEN LINK) with tryptophan residues presumably blocks the preS1 binding site preventing proper infection.
== Function ==
== Function ==

Revision as of 17:32, 27 March 2023

Sodium-taurocholate Co-transporting Polypeptide

Sodium-taurocholate co-transporting Polypeptide (NTCP) 7PQQ

Drag the structure with the mouse to rotate

References

  1. Asami J, Kimura KT, Fujita-Fujiharu Y, Ishida H, Zhang Z, Nomura Y, Liu K, Uemura T, Sato Y, Ono M, Yamamoto M, Noda T, Shigematsu H, Drew D, Iwata S, Shimizu T, Nomura N, Ohto U. Structure of the bile acid transporter and HBV receptor NTCP. Nature. 2022 Jun; 606 (7916):1021-1026. DOI: 10.1038/s41586-022-04845-4.
  2. Goutam K, Ielasi FS, Pardon E, Steyaert J, Reyes N. Structural basis of sodium-dependent bile salt uptake into the liver. Nature. 2022 Jun;606(7916):1015-1020. DOI: 10.1038/s41586-022-04723-z.
  3. Park JH, Iwamoto M, Yun JH, Uchikubo-Kamo T, Son D, Jin Z, Yoshida H, Ohki M, Ishimoto N, Mizutani K, Oshima M, Muramatsu M, Wakita T, Shirouzu M, Liu K, Uemura T, Nomura N, Iwata S, Watashi K, Tame JRH, Nishizawa T, Lee W, Park SY. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature. 2022 Jun;606(7916):1027-1031. DOI: 10.1038/s41586-022-04857-0.
  4. Liu H, Irobalieva RN, Bang-Sørensen R, Nosol K, Mukherjee S, Agrawal P, Stieger B, Kossiakoff AA, Locher KP. Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver. Cell Res. 2022 Aug;32(8):773-776. DOI: 10.1038/s41422-022-00680-4.
  5. Qi X, Li W. Unlocking the secrets to human NTCP structure. Innovation (Camb). 2022 Aug 1;3(5):100294. doi: 10.1016/j.xinn.2022.100294. DOI: 10.1016/j.xinn.2022.100294.
  6. Zhang X, Zhang Q, Peng Q, Zhou J, Liao L, Sun X, Zhang L, Gong T. Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells. Biomaterials. 2014 Jul;35(23):6130-41. doi: 10.1016/j.biomaterials.2014.04.037. DOI: 10.1016/j.biomaterials.2014.04.037.

Student Contributors

  • Ben Minor
  • Maggie Samm
  • Zac Stanley
Personal tools